Navigation Links
Sensus Healthcare Announces Its Exhibitor Attendance at the 9th Annual South Beach Symposium™
Date:2/17/2011

BOCA RATON, Fla., Feb. 17, 2011 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 9th Annual South Beach Symposium™ in Miami Beach, FL on February 17-21, 2011.  The South Beach Symposium™ is a comprehensive session with three non-overlapping tracks in clinical dermatology, aesthetics, and practice management. Sensus Healthcare is featuring superficial radiotherapy (SRT) with their SRT-100™ advanced platform as a complimentary tool for the dermatologists and Mohs surgeons and as a non-surgical option for their patients. Dr. Gary D. Monheit is a keynote speaker at the symposium, reviewing the advantages of SRT and its pertinence and benefits to the dermatology practices and non-melanoma skin cancer patients, with a presentation titled "Radiation Therapy in the Treatment of Skin Cancer: Back Home to Dermatology" on Sunday February 20, 2011 at 9:00AM Eastern. Visit Sensus (booth #416) at the 9th South Beach Symposium™ to be held at the Loews Miami Beach Hotel to learn about the SRT-100™ low-dose non-invasive superficial radiotherapy (SRT) non-melanoma skin cancer therapy solution.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO)

"Sensus is very excited to be participating in this year's South Beach Symposium. We are looking forward to meeting with key leaders of Dermatology as we present the SRT-100™ as a compliment to their existing array of skin cancer treatments" –Steve Cohen (Vice President of Strategic Initiatives, Sensus Healthcare)

About Sensus Healthcare:Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions™, through our physician SRT-100™ users for their patients.

About South Beach Symposium™:The South Beach Symposium is designed to meet the needs of physicians, nurses and professional staff members of medical practices specializing in dermatology, plastic surgery, cosmetic surgery, pediatric dermatology and other dermatologic medical procedures. The symposium features three non–overlapping CME tracks – the South Beach Clinical Dermatology Symposium, the South Beach Aesthetics Symposium and the Practice Management Symposium.Contact:Vicky PerezPublic Relations561-922-5808 Ext 108vicky@sensushealthcare.com
'/>"/>

SOURCE Sensus Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sensus Healthcare Announces the Formation of a Medical Advisory Board
2. Sensus Healthcare Announces New Professional Skin Care Line - Sensus Skin Solutions™
3. Sensus Healthcare Announces Strategic Partnership With Flagship Solutions Group
4. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
5. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
6. New consensus on work-related asthma
7. Shionogi-ViiV Healthcare Starts Phase III Trial for 572-Trii Fixed-Dose Combination HIV Therapy
8. Anthera Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
9. Biodel Inc. to Present at 29th Annual JPMorgan Healthcare Conference on January 13th, 2011
10. Orexigen® Therapeutics to Present at JP Morgan Healthcare Conference
11. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):